Anders A F Sima Selected Research

hypoglycemic encephalopathy

1/2009	Inflammation in Diabetic Encephalopathy is Prevented by C-Peptide.
1/2009	Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide.
1/2008	Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes?
1/2008	The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.
3/2005	The role of impaired insulin/IGF action in primary diabetic encephalopathy.
4/2004	Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anders A F Sima Research Topics

Disease

27	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2012 - 10/2002
22	Diabetic Neuropathies (Diabetic Neuropathy) 11/2011 - 03/2002
14	Hyperglycemia 01/2014 - 03/2003
7	Type 2 Diabetes Mellitus (MODY) 01/2007 - 05/2004
6	hypoglycemic encephalopathy 01/2009 - 04/2004
4	Atrophy 01/2014 - 12/2004
4	Cognitive Dysfunction 01/2008 - 08/2002
3	Hyperalgesia 12/2006 - 09/2004
3	Crush Injuries 07/2003 - 02/2002
2	Insulin Resistance 01/2014 - 10/2009
2	Alzheimer Disease (Alzheimer's Disease) 12/2010 - 05/2010
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 07/2010 - 10/2008
2	Brain Edema (Cerebral Edema) 07/2010 - 10/2008
2	Brain Diseases (Brain Disorder) 01/2008 - 05/2005
2	Neuralgia (Stump Neuralgia) 01/2007 - 01/2005
2	Diabetes Complications 04/2006 - 01/2004
2	Neuroblastoma 01/2004 - 09/2003
1	Ketosis 07/2010
1	Intellectual Disability (Idiocy) 05/2010
1	Autism Spectrum Disorder 05/2010
1	Pelizaeus-Merzbacher Disease 10/2009
1	Inflammation (Inflammations) 01/2009
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2007
1	Diabetes Mellitus 01/2007
1	Memory Disorders (Memory Loss) 05/2005
1	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile) 05/2004
1	Polyneuropathies (Polyneuropathy) 01/2004

Drug/Important Bio-Agent (IBA)

26	C-PeptideIBA 04/2012 - 10/2002
22	Insulin (Novolin)FDA Link 01/2014 - 03/2002
11	NAD (NADH)IBA 01/2009 - 03/2003
4	Proteins (Proteins, Gene)FDA Link 10/2009 - 02/2002
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 07/2010 - 03/2003
3	Acetylcarnitine (Alcar)IBA 05/2008 - 01/2005
3	Insulin-Like Growth Factor I (IGF-1)IBA 05/2004 - 08/2002
2	Nerve Growth Factors (Neurotrophins)IBA 01/2009 - 11/2006
2	Nerve Growth Factor (NGF)IBA 03/2005 - 07/2003
2	Streptozocin (Streptozotocin)FDA Link 09/2004 - 05/2004
1	Amyloid (Amyloid Fibrils)IBA 12/2010
1	SodiumIBA 05/2010
1	Protons (Proton)IBA 05/2010
1	PhosphatidylserinesIBA 10/2009
1	Glucose (Dextrose)FDA LinkGeneric 10/2009
1	Metformin (Glucophage)FDA LinkGeneric 10/2009
1	ZincIBA 10/2009
1	Triglycerides (Triacylglycerol)IBA 07/2009
1	NF-kappa B (NF-kB)IBA 01/2009
1	Receptor for Advanced Glycation End ProductsIBA 10/2008
1	Adenosine Triphosphatases (ATPase)IBA 01/2008
1	Sterol Regulatory Element Binding Protein 1IBA 08/2007
1	Insulin ReceptorIBA 07/2007
1	Glycogen Synthase Kinase 3 betaIBA 07/2007
1	Aldehyde Reductase (Aldose Reductase)IBA 04/2006
1	AntioxidantsIBA 04/2006
1	Calcitonin Gene-Related PeptideIBA 11/2005
1	Substance PIBA 11/2005
1	CaspasesIBA 03/2005
1	Therapeutic UsesIBA 09/2003
1	Insulin-Like PeptidesIBA 07/2003
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 08/2002
1	Messenger RNA (mRNA)IBA 02/2002
1	TubulinIBA 02/2002

Therapy/Procedure

4	Therapeutics 01/2014 - 01/2004
1	Subcutaneous Injections 12/2006